Takeda makes fourth offer to buy Shire

Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion ($61.6 billion).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

31 October 2018 Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Americas

Lundbeck and Takeda take on Lupin over anti-depressant ANDA

23 May 2018 Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

More on this story

Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

31 October 2018 Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Americas

Lundbeck and Takeda take on Lupin over anti-depressant ANDA

23 May 2018 Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

More on this story

Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

31 October 2018 Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Americas

Lundbeck and Takeda take on Lupin over anti-depressant ANDA

23 May 2018 Pharmaceutical companies Lundbeck and Takeda have sued generic drug producer Lupin for infringing a patent directed to anti-depressant medication Trintellix (vortioxetine hydrobromide).

Big Pharma

Japanese Takeda to acquire Shire for $62bn

8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.